1. Home
  2. VLN vs ONCY Comparison

VLN vs ONCY Comparison

Compare VLN & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valens Semiconductor Ltd.

VLN

Valens Semiconductor Ltd.

HOLD

Current Price

$2.12

Market Cap

116.9M

Sector

Technology

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.80

Market Cap

98.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLN
ONCY
Founded
2006
1998
Country
Israel
Canada
Employees
233
N/A
Industry
Semiconductors
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.9M
98.7M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
VLN
ONCY
Price
$2.12
$0.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$3.00
$7.33
AVG Volume (30 Days)
3.9M
1.4M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.37
N/A
Revenue Next Year
$16.99
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$0.49
52 Week High
$3.71
$1.51

Technical Indicators

Market Signals
Indicator
VLN
ONCY
Relative Strength Index (RSI) 39.13 40.46
Support Level $1.48 N/A
Resistance Level $2.64 $1.14
Average True Range (ATR) 0.40 0.08
MACD -0.19 -0.01
Stochastic Oscillator 21.43 2.23

Price Performance

Historical Comparison
VLN
ONCY

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: